Zipcode Bio is a biotechnology company specializing in the development of next-generation nucleic acid applications that are accessible, widely distributable, and superior in efficacy and safety. Its co-founders include Dr. Jason Zhang and Dr. Drew Weissman, Nobel Laureate 2023.
The scientific strength is based on the co-founders’ deep knowledge in RNA medicine, liver and extra-hepatic deliveries, and focus on unmet medical needs. Zipcode Bio stands at the forefront of developing revolutionary solutions with publications in Nature Communications, Nature Machine Intelligence and others.
Zipcode Bio has assembled a dynamic team committed to pushing scientific boundaries and developing novel therapeutics to address unmet healthcare needs. The company’s dedication to innovation, precision, and accessibility underscores its mission to improve therapeutic outcomes and contribute to the evolution of global healthcare.